Evidence map›Paper›PMID 41311852›Full record

ArticleFrontiers in pharmacology2025

Implementation of medication review type 2a in community pharmacies: a longitudinal survey study.

Eline Tobback, Isabelle De Wulf, Ella Wauters, Delia Mendez Santos, Stéphanie Patris, Olivia Dalleur, Eline Tommelein, Veerle Foulon, Geneviève Philippe, Carine De Vriese and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Eline TobbackLaboratory of Physiopharmacology, University of Antwerp (UA), Antwerp, Belgium.
Isabelle De WulfAssociation of Pharmacists Belgium (APB), Antwerp, Belgium.
Ella WautersLaboratory of Physiopharmacology, University of Antwerp (UA), Antwerp, Belgium.
Delia Mendez SantosLaboratory of Physiopharmacology, University of Antwerp (UA), Antwerp, Belgium.
Stéphanie PatrisClinical Pharmacy Unit, Faculty of Medicine, Pharmacy and Biomedical Sciences, University of Mons (UMONS), Mons, Belgium.
Olivia DalleurClinical Pharmacy and Pharmacoepidemiology Research Group, Louvain Drug Research Institute, UCLouvain, Brussels, Belgium.
Eline TommeleinDepartment of Pharmacological and Pharmaceutical Sciences, Research Group Experimental Pharmacology, Vrije Universiteit Brussel, Jette, Belgium.
Veerle FoulonDepartment of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy, KU Leuven, Leuven, Belgium.
Geneviève PhilippeCenter for Interdisciplinary Research on Medicines (CIRM)/Pharmacy Practice Research Group, University of Liège, Liège, Belgium.
Carine De VrieseService de Pharmacologie, Pharmacothérapie et Suivi Pharmaceutique, Université Libre de Bruxelles, Brussels, Belgium.
Stephane SteurbautPharmacy Department, Universitair Ziekenhuis Brussel (UZ Brussel), Jette, Belgium.
Nathalie DuquetAssociation of Pharmacists Belgium (APB), Antwerp, Belgium.
Guido R Y De MeyerLaboratory of Physiopharmacology, University of Antwerp (UA), Antwerp, Belgium.
Hans De LoofLaboratory of Physiopharmacology, University of Antwerp (UA), Antwerp, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Medication Review Type 2a (MR2a), introduced to enhance medication use and health outcomes, has been reimbursed in Belgian community pharmacies since April 2023; however, its implementation status remains unreported. Aim: This longitudinal survey study aimed to document MR2a implementation among community pharmacists by identifying both facilitating and hindering factors. Methods: A bilingual online survey was distributed quarterly from October 2023 to October 2024 to all Belgian community pharmacies. The 45-item questionnaire-featuring multiple-choice, Likert scale, and open-ended questions-captured pharmacists' experiences about MR2a. Results: Across all rounds ( Conclusion: Repeated surveys offer timely insights into MR2a implementation in community pharmacies. The slow progress confirms existing obstacles and stresses the importance of continued support and improved interprofessional collaborations. These insights are expected to inform MR implementation locally and internationally.

Indexed as

community pharmacy serviceshealth policyhealth services accessibilityinterprofessional relationsmedication therapy managementpharmaceutical servicessurveys and questionnaires

Identifiers

PMID41311852
PMCPMC12648213

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.